Clinical Trials Directory

Trials / Completed

CompletedNCT04854785

Neuroinflammation in COVID-19 and Depression

Imaging Neuroinflammation in COVID-19 and Persistent Depression With/Without Other Neuropsychiatric Symptoms

Status
Completed
Phase
Study type
Observational
Enrollment
77 (actual)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to use state of the art brain imaging technology to investigate neuroinflammation in participants with depression after the respiratory symptoms of coronavirus disease 2019 (COVID-19) have passed.

Detailed description

Participants will undergo two positron emission tomography (PET) scans: one \[18F\]FEPPA scan (for translocator protein (TSPO)) and one \[11C\]SL25.1188 scan (for monoamine oxidase B (MAO-B)) - as well as one magnetic resonance imaging (MRI) scan. The primary hypotheses are: 1. TSPO total distribution volume (TSPO VT) and MAO-B total distribution volume (MAO-B VT) are greater in the prefrontal cortex (PFC), anterior cingulate cortex (ACC), and hippocampus in COVID-19 with new onset, persistent major depressive episode (MDE) with or without other neuropsychiatric symptoms after recovery from mild respiratory symptoms (DNP-mild). 2. TSPO VT and MAO-B VT are greater in the PFC, ACC, and hippocampus in COVID-19 with new onset, persistent MDE with or without other persistent neuropsychiatric symptoms after recovery from moderate respiratory symptoms (DNP-moderate). Exploratory hypotheses are: 1. Greater TSPO VT and MAO-B VT in the PFC, ACC, and hippocampus will be positively associated with severity of MDE symptoms and poorer performance on cognitive tasks. 2. TSPO VT and MAO-B VT will be positively correlated in the PFC, ACC and hippocampus in COVID-DNP.

Conditions

Interventions

TypeNameDescription
OTHER[18F]FEPPA PET scanOne \[18F\]FEPPA PET for TSPO VT, and one MRI scan
OTHER[11C]SL25.1188 PET scanOne \[11C\]SL25.1188 PET scan for MAO-B VT, and one MRI scan

Timeline

Start date
2021-06-14
Primary completion
2023-12-21
Completion
2023-12-21
First posted
2021-04-22
Last updated
2025-04-22

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04854785. Inclusion in this directory is not an endorsement.